Neonatal Oximeter Bias Study

NCT ID: NCT06817850

Last Updated: 2025-03-25

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Total Enrollment: 40 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-03-15
• Study Completion Date: 2025-10-31

Brief Summary

The study aims to determine if there is a systematic difference (bias) between pulse oximeters used in control systems for automated oxygen delivery (A-FiO2) and those used in monitoring systems.

When using A-FiO2 systems there are commonly two oximeter probes on the infant with two difference readouts. Nurses report frustration that the two readings are often markedly different. It is understandable that physiological differences between sensor sites might reflect different regional oxygen saturation levels. It is also possible that there is a relevant systematic bias between difference monitors and sensors.

Therefore, a large systematic multicenter study is needed to determine whether these frequent differences should be ignored as physiological noise or considered clinically relevant.

Detailed Description

The accuracy of clinical pulse oximeters is specified as 3% RMS (root mean squared of the bias and variance) compared to arterial SaO2, in the range of 70-100% SpO2. This combines errors from bias and from scatter (imprecision). These validations are carried out under ideal laboratory conditions; that is, on healthy volunteers who undergo experimental desaturations, and not in the routine clinical environment. In a large multicenter clinical observation study, Ross et al in 2013 identified important related concerns. Specifically, they found that many of the clinical measurements were outside the 3% accuracy envelop. Specifically, they reported that bias varied depending on the level of saturation, the oximeter brand, sensor, race and site perfusion. Others have identified relevant differences in oximeters, oximeter sensors [Maiwald], and skin pigmentation.

Our study would be the first study in the neonatal ICU evaluating bias to consider different oximeters, sensors and sensor sites. It is highly topical in that changes in average SpO2 of 3% have been associated with excess neonatal mortality and morbidity.

This study is planned to investigate the source and magnitude of differences in SpO2 readings from oximeter sensors at different sensor sites that are routinely noticed by clinicians. While these differences are most often ignored and attributed to sensor site perfusion, if systematic they could have marked impact on mortality and morbidity.

The aim of the investigation is to provide practical guidance relating to SpO2 bias among oximeters, oximeter sensors and sensor location. While taking advantage of the clinical need for 2 oximeter sensors, the results will be applicable to all neonatal oximeter monitoring.

An observational design was selected to take place in centers using automated FiO2 control systems (A-FiO2) that routinely require the use of one sensor for control and another for monitoring. This is a refinement of the approach used in the often-cited multicenter evaluation of neonatal SpO2 exposure. Thus, without an investigational intervention the observational design is well suited to collect comparable data from multiple centers.

Conditions

Neonatal Respiratory Distress; Oxygenation

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Infants in the NICU with two oximeters

Infants in the NICU monitored with two oximeters with probes in preductal locations. The use of A-FiO2 is expected.

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Observations of any infant in the neonatal ICU with two simultaneous oximeter monitors may be included. The sites' Ethics Committee must review the protocol, approve participation and determine if Informed Consent is required. If required, it might be prospective, that is prior to collecting any data, or retrospective.

Exclusion Criteria

• One oximeter monitoring post ductal SpO2 in infant with clinically relevant shunt.
• Monitor and A-FiO2 Oximeter not reading between 70-100%
• Less than 5 minutes between repeat Observations
• No more than 5 measurements per day per subject with sensors in same position and same oximeters (i.e., every time either sensor is moved, 5 new Observations can be made that day).
• Presence of motion artifact
• Presence of sensor integrity alarms/alerts

• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University Hospital, Motol

OTHER

Sponsor Role: collaborator

Czech Technical University in Prague

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Thomas E Bachman, MSc

Role: PRINCIPAL_INVESTIGATOR

Czech Technical University in Prague

Jan Janota, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Motol University Hospital

Locations

Motol University Hospital, Neonatal Unit

Prague, , Czechia

Countries

Czechia

Central Contacts

Jakub Rafl, PhD

Role: CONTACT

rafl@fbmi.cvut.cz

+420728229991

Facility Contacts

Jana Dornakova, MD

Role: primary

Jana.Dornakova@fnmotol.cz

+420607720060

Other Identifiers

NOB (PRICOIII)

Identifier Type: -

Identifier Source: org_study_id